scd50 (STATA Corporation)
STATA Corporation is a verified supplier 
99
Structured Review
STATA Corporation
scd50
Scd50, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 9319 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/scd50/STATA+8%2E0/pm24615356-50-37-54
Average 99 stars, based on 9319 article reviews
Scd50, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 9319 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/scd50/STATA+8%2E0/pm24615356-50-37-54
Average 99 stars, based on 9319 article reviews
scd50 - by Bioz Stars,
2026-09
99/100 stars
Images
Related Articles
Cellenone:Article Title: Potential of a Cetuximab-based radioimmunotherapy combined with external irradiation manifests in a 3-D cell assay. Article Snippet: M. Ingargiola, R. Runge, J.-M. Heldt, R. Freudenberg, J. Steinbach, N. Cordes, M. Baumann, J. Kotzerke, G. Brockhoff and L.A. Kunz-Schughart 1 OncoRay—National Center for Radiation Research in Oncology, Medical Faculty Carl Gustav Carus, TU Dresden, Dresden, Germany 2 Institute of Radiooncology, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany 3 Department of Nuclear Medicine, Medical Faculty and University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany 4 Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany 5 Department of Radiation Oncology, Medical Faculty and University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany 6 Department of Gynecology and Obstetrics, University of Regensburg, Regensburg, Germany Control:Article Title: Potential of a Cetuximab-based radioimmunotherapy combined with external irradiation manifests in a 3-D cell assay. Article Snippet: M. Ingargiola, R. Runge, J.-M. Heldt, R. Freudenberg, J. Steinbach, N. Cordes, M. Baumann, J. Kotzerke, G. Brockhoff and L.A. Kunz-Schughart 1 OncoRay—National Center for Radiation Research in Oncology, Medical Faculty Carl Gustav Carus, TU Dresden, Dresden, Germany 2 Institute of Radiooncology, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany 3 Department of Nuclear Medicine, Medical Faculty and University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany 4 Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany 5 Department of Radiation Oncology, Medical Faculty and University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany 6 Department of Gynecology and Obstetrics, University of Regensburg, Regensburg, Germany Software:Article Title: Potential of a Cetuximab-based radioimmunotherapy combined with external irradiation manifests in a 3-D cell assay. Article Snippet: M. Ingargiola, R. Runge, J.-M. Heldt, R. Freudenberg, J. Steinbach, N. Cordes, M. Baumann, J. Kotzerke, G. Brockhoff and L.A. Kunz-Schughart 1 OncoRay—National Center for Radiation Research in Oncology, Medical Faculty Carl Gustav Carus, TU Dresden, Dresden, Germany 2 Institute of Radiooncology, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany 3 Department of Nuclear Medicine, Medical Faculty and University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany 4 Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany 5 Department of Radiation Oncology, Medical Faculty and University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany 6 Department of Gynecology and Obstetrics, University of Regensburg, Regensburg, Germany Irradiation:Article Title: Potential of a Cetuximab-based radioimmunotherapy combined with external irradiation manifests in a 3-D cell assay. Article Snippet: M. Ingargiola, R. Runge, J.-M. Heldt, R. Freudenberg, J. Steinbach, N. Cordes, M. Baumann, J. Kotzerke, G. Brockhoff and L.A. Kunz-Schughart 1 OncoRay—National Center for Radiation Research in Oncology, Medical Faculty Carl Gustav Carus, TU Dresden, Dresden, Germany 2 Institute of Radiooncology, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany 3 Department of Nuclear Medicine, Medical Faculty and University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany 4 Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany 5 Department of Radiation Oncology, Medical Faculty and University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany 6 Department of Gynecology and Obstetrics, University of Regensburg, Regensburg, Germany |